98 filings
Page 2 of 5
8-K
v09cap
19 May 20
Departure of Directors or Certain Officers
5:15pm
8-K
iaymbbzha
14 May 20
Other Events
5:00pm
8-K
98l0xz4zlvtv33flur2d
20 Mar 20
Amendments to Articles of Incorporation or Bylaws
3:15pm
8-K
i1lb84io9kztrv2apdwj
11 Feb 20
Departure of Directors or Certain Officers
4:30pm
8-K
wm2p8hrv8cqc8m3vq
28 Jan 20
Entry into a Material Definitive Agreement
6:11am
8-K
qx8sf
27 Jan 20
Nanoviricides Closes on $8.625 Million Underwritten Public Offering of Common Stock
5:12pm
8-K/A
kkds62a odnv73xt
2 Jan 20
Entry into a Material Definitive Agreement
12:39pm
8-K
52lf9x yh37b
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
8-K
vyy8frsd4v6xs5dmqah
13 Dec 19
NanoViricides President Dr. Anil Diwan Provides Responses to Shareholder Questions at the Annual Meeting of Shareholders
5:19pm
8-K
sd9vgr jx1no74
5 Nov 19
NanoViricides Completes Licensing for VZV Field which Includes Shingles Drug Development
9:39pm
8-K
ec3jqlz5ux7p0
26 Sep 19
Amendments to Articles of Incorporation or Bylaws
6:02am
8-K
qdq5pi
1 Aug 19
Departure of Directors or Certain Officers
4:30pm
8-K
tnq51x9wjpabnq14
10 Jun 19
Departure of Directors or Certain Officers
6:02am
8-K
us5uwq8
1 Mar 19
NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering
6:11am
8-K
ivzccse2
1 Feb 19
Departure of Directors or Certain Officers
4:41pm
8-K
iq10gcd65u3f lw4
7 Dec 18
Submission of Matters to a Vote of Security Holders
4:38pm
8-K
1glzdoy983ivp6
31 Oct 18
Departure of Directors or Certain Officers
5:21pm
8-K/A
fvqzipfldx
12 Sep 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
0eo4s8btse0jhx1z7c
23 Jul 18
Entry into a Material Definitive Agreement
4:43pm
8-K
0ve kmx413nr9nom9lo
19 Jul 18
Entry into a Material Definitive Agreement
12:00am